Literature DB >> 25951904

A clinical approach to diagnose patients with localized telangiectasia.

Ruchi Gupta1, Ram Krishan Gautam1, Minakshi Bhardwaj2, Amrita Chauhan1.   

Abstract

Telangiectasia, or dilated blood vessels, may represent a benign condition or a marker of a much more serious internal or cutaneous malignancy (e.g., mycosis fungoides). They can be generalized or localized in distribution. 'Localized telangiectasia? can be macular or papular. Macular ones can be further divided into two major categories: primary and secondary. They can occur on their own (primary), after skin injury (e.g., sun damage, post-radiation therapy, after prolonged topical steroid application), or may arise due to an underlying condition (secondary). While telangiectases can spring from a multitude of possible causes, the location of the lesions, in combination with a careful history and exmination, often helps in elucidating the correct diagnosis. A patient with localized telangiectasia as a manifestation of malignancy may be difficult to diagnose, however the diagnosis is one of exclusion, and a thorough evaluation should be performed before diagnosing this condition. This article reviews possible conditions to consider in these patients and suggests an approach to their evaluation.
© 2015 The International Society of Dermatology.

Entities:  

Mesh:

Year:  2015        PMID: 25951904     DOI: 10.1111/ijd.12629

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  2 in total

1.  Dermatologic Vasculature Diseases as a Risk Factor of Subconjunctival Hemorrhage.

Authors:  Chia-Yi Lee; Hung-Chi Chen; Jing-Yang Huang; Chi-Chin Sun; Chao-Bin Yeh; Hung-Yu Lin; Shun-Fa Yang
Journal:  Int J Environ Res Public Health       Date:  2019-08-10       Impact factor: 3.390

2.  Angioma serpiginosum in zosteriform distribution on abdomen: A rare presentation.

Authors:  Kamal P Acharya; Prajwal Pandey; Rajan Shah; Muna Bista; Samir Shrestha
Journal:  Clin Case Rep       Date:  2021-03-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.